The latest issue of the Australasian Journal of Biotechnology (Volume 35, Number 2) is now available, showcasing the people and ideas shaping Australia’s life sciences future.
This edition explores how emerging start-ups are reimagining health, spotlights Australia’s advanced therapies sector, and examines the growing importance of patient engagement in research and innovation.
Readers will also find highlights from AusMedtech, AusMedtech Invest, and the Early-Stage Innovation Forum — events that continue to strengthen the connection between research, development, and commercialisation across Australia’s biotech and medtech ecosystem.
As Australia’s life sciences sector continues to expand, the Australasian Journal of Biotechnology remains a key platform for sharing sector insights, emerging trends, and success stories that drive national and global impact. It provides a forum for industry, researchers, and investors to connect, collaborate, and advance breakthrough innovations from research to real-world application.
The Journal features submissions from:
- CCRM Australia
- Bridge Investment Research
- Advancell
- FB Rice
- PTNG Scientific
- Cicada Innovations
- Breakthrough T1D
- Agriculture Victoria Services Pty Ltd
- ZiP Diagnostics
- and more...
The Australasian Journal of Biotechnology is available now on the AusBiotech website.